About SANUWAVE Health (OTCMKTS:SNWV)
SANUWAVE Health, Inc. is an acoustic pressure shock wave technology company using a system of noninvasive, high-energy, acoustic pressure shock waves for indications, such as regenerative medicine and other applications. The Company is focused on regenerative medicine utilizing noninvasive (extracorporeal), acoustic pressure shock waves to produce a biological response resulting in the body healing itself through the repair and regeneration of skin, musculoskeletal tissue and vascular structures. Its lead regenerative product in the United States is the dermaPACE device, used for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, enabling to restore the body's normal healing processes and regeneration. It is focused on developing its Pulsed Acoustic Cellular Expression (PACE) technology to activate healing in wound conditions.
Industry, Sector and Symbol
Industry MED PRODS
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Annual Sales$1.38 million
Price / Sales50.15
Price / CashN/A
Book Value($0.05) per share
Price / Book-9.94
Return on EquityN/A
Return on Assets-666.33%
SANUWAVE Health (OTCMKTS:SNWV) Frequently Asked Questions
What is SANUWAVE Health's stock symbol?
SANUWAVE Health trades on the OTCMKTS under the ticker symbol "SNWV."
How were SANUWAVE Health's earnings last quarter?
SANUWAVE Health, Inc. (OTCMKTS:SNWV) released its quarterly earnings data on Monday, November, 20th. The company reported ($0.01) earnings per share for the quarter, meeting the Thomson Reuters' consensus estimate of ($0.01). The business had revenue of $0.16 million for the quarter, compared to the consensus estimate of $0.48 million. View SANUWAVE Health's Earnings History.
When will SANUWAVE Health make its next earnings announcement?
Who are some of SANUWAVE Health's key competitors?
Some companies that are related to SANUWAVE Health include Zynex (ZYXI), HTG Molecular Diagnostics (HTGM), Viveve Medical (VIVE), Second Sight Medical Products (EYES), Apollo Endosurgery (APEN), Veru (VERU), Oramed Pharmaceuticals (ORMP), Ekso Bionics (EKSO), Vermillion (VRML), ConforMIS (CFMS), Alphatec (ATEC), Biolife Solutions (BLFS), Obalon Therapeutics (OBLN), Invuity (IVTY), Edap Tms (EDAP), Presbia (LENS), Arch Therapeutics (ARTH) and BIOLASE (BIOL).
Who are SANUWAVE Health's key executives?
SANUWAVE Health's management team includes the folowing people:
- Kevin A. Richardson II, Chairman of the Board, Co-Chief Executive Officer (Age 46)
- Lisa E. Sundstrom, Chief Financial Officer (Age 45)
- Maj-Britt Kaltoft, Director
- John Fritzen Nemelka, Director (Age 49)
- A. Michael Stolarski, Director
- Alan L. Rubino, Independent Director (Age 60)
Has SANUWAVE Health been receiving favorable news coverage?
Media stories about SNWV stock have trended somewhat positive this week, Accern Sentiment reports. The research firm identifies positive and negative news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. SANUWAVE Health earned a media sentiment score of 0.22 on Accern's scale. They also assigned media stories about the company an impact score of 45.08 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next few days.
How do I buy shares of SANUWAVE Health?
Shares of SNWV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is SANUWAVE Health's stock price today?
One share of SNWV stock can currently be purchased for approximately $0.50.
How big of a company is SANUWAVE Health?
SANUWAVE Health has a market capitalization of $68.23 million and generates $1.38 million in revenue each year. The company earns $-6,430,000.00 in net income (profit) each year or ($0.04) on an earnings per share basis. SANUWAVE Health employs 6 workers across the globe.
How can I contact SANUWAVE Health?
SANUWAVE Health's mailing address is 3360 Martin Farm Road Suite 100, Suwanee GA, 30024. The company can be reached via phone at 770-419-7525 or via email at [email protected]
MarketBeat Community Rating for SANUWAVE Health (SNWV)MarketBeat's community ratings are surveys of what our community members think about SANUWAVE Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
SANUWAVE Health (OTCMKTS:SNWV) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
SANUWAVE Health (OTCMKTS:SNWV) Earnings History and Estimates Chart
SANUWAVE Health (OTCMKTS SNWV) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|4/3/2018|| || || || || || || || |
|11/20/2017||Q3 2017||($0.01)||($0.01)||$0.48 million||$0.16 million||View||N/A|
|8/14/2017||Q2 2017||($0.01)||($0.01)||$0.24 million||$0.11 million||View||N/A|
|4/4/2017||Q4 2016||($0.01)||($0.02)||$0.65 million||$0.65 million||View||N/A|
|11/8/2016||Q3 2016||($0.01)||($0.01)||$0.33 million||$0.26 million||View||N/A|
|8/15/2016||Q2 2016||($0.01)||($0.01)||$0.34 million||$0.20 million||View||N/A|
|5/17/2016||Q1 2016||($0.02)||($0.02)||$0.19 million||$0.27 million||View||N/A|
|3/30/2016||Q4 2015||($0.02)||($0.02)||$0.33 million||$0.37 million||View||N/A|
|11/12/2015||Q3 2015||($0.02)||($0.02)||$0.24 million||$0.14 million||View||N/A|
|8/11/2015||Q2 2015||($0.02)||($0.02)||$0.23 million||$0.24 million||View||N/A|
|5/6/2015||Q1 2015||($0.02)||($0.02)||$0.25 million||$0.21 million||View||N/A|
|11/12/2014||Q3 2014||($0.04)||($0.03)||$0.19 million||$0.23 million||View||N/A|
|8/6/2014||($0.04)||($0.03)||$0.20 million||$0.24 million||View||N/A|
|5/13/2014||Q1 2014||($0.05)||($0.06)||$0.15 million||$0.15 million||View||N/A|
|11/12/2013||($0.08)||($0.06)||$0.21 million||$0.15 million||View||N/A|
|8/14/2013||Q2 2013||($0.10)||($0.09)||$0.17 million||$0.16 million||View||N/A|
|5/14/2013||Q1 2013||($0.07)||($0.07)||$0.16 million||$0.20 million||View||N/A|
SANUWAVE Health (OTCMKTS:SNWV) Earnings Estimates
Current Year EPS Consensus Estimate: $-0.03 EPS
Next Year EPS Consensus Estimate: $-0.02 EPS
Dividend History for SANUWAVE Health (OTCMKTS:SNWV)
No dividend announcements for this company have been tracked by MarketBeat.com
SANUWAVE Health (OTCMKTS SNWV) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 23.40%
Institutional Ownership Percentage: 0.47%
SANUWAVE Health (OTCMKTS SNWV) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|9/28/2016||Anthony Michael Stolarski||Director||Buy||500,000||$0.06||$30,000.00||3,724,626|| |
|3/17/2014||Joseph Chiarelli||CEO||Buy||80,000||$0.50||$40,000.00|| |
|3/17/2014||Kevin A Richardson II||Director||Buy||100,000||$0.50||$50,000.00|| |
|10/9/2013||Joseph Chiarelli||CEO||Buy||41,667||$0.60||$25,000.20|| |
|10/9/2013||Kevin A Richardson II||Director||Buy||35,312||$0.60||$21,187.20|| |
|9/19/2013||Barry J Jenkins||CFO||Buy||13,500||$0.74||$9,990.00|| |
|8/13/2013||Christopher M Cashman||Major Shareholder||Sell||33,500||$0.77||$25,795.00|| |
|6/11/2013||Christopher M Cashman||Major Shareholder||Sell||34,800||$0.80||$27,840.00|| |
|6/6/2013||Christopher M Cashman||Major Shareholder||Sell||46,100||$0.89||$41,029.00|| |
|5/29/2013||Christopher M Cashman||Major Shareholder||Sell||2,827||$0.84||$2,374.68|| |
|5/22/2013||Christopher M Cashman||Major Shareholder||Sell||73,461||$0.96||$70,522.56|| |
|5/17/2013||Christopher M Cashman||Major Shareholder||Sell||26,539||$1.00||$26,539.00|| |
|11/27/2012||David Nephi Jr. Nemelka||Major Shareholder||Buy||4,000,000||$0.25||$1,000,000.00|| |
SANUWAVE Health (OTCMKTS SNWV) News Headlines
SANUWAVE Health (OTCMKTS:SNWV) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
SANUWAVE Health (OTCMKTS SNWV) Stock Chart for Tuesday, March, 20, 2018